The proton pump inhibitor (PPI) test in GERD: Does it still have a role?

Journal of Clinical Gastroenterology

Volumn 42, Issue 8, 2008, Pages 867-874

  Gasiorowska, Anita ^a   Fass, Ronnie ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Erosive esophagitis; Extraesophageal manifestations of GERD; Gastroesophageal reflux disease; Noncardiac chest pain; Nonerosive reflux disease; PPI test; Proton pump inhibitor

Indexed keywords

ACID; BARIUM; EDROPHONIUM CHLORIDE; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; RABEPRAZOLE; ANTIULCER AGENT; DIAGNOSTIC AGENT; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ESOPHAGUS ACHALASIA; ESOPHAGUS INJURY; ESOPHAGUS MOTILITY; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEARTBURN; HUMAN; MANOMETRY; NONCARDIAC CHEST PAIN; PREVALENCE; PRIORITY JOURNAL; PROTON PUMP INHIBITOR TEST; PROVOCATION TEST; QUALITY OF LIFE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; ULCERATIVE ESOPHAGITIS; DIGESTIVE SYSTEM EXAMINATION; ECONOMICS; META ANALYSIS; THORAX PAIN;

ANTI-ULCER AGENTS; CHEST PAIN; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; GASTROESOPHAGEAL REFLUX; HUMANS; META-ANALYSIS AS TOPIC; PROTON PUMP INHIBITORS; SENSITIVITY AND SPECIFICITY;

EID: 54549088750     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31816c47ed     Document Type: Review

References (60)

1. Joseph S, Hirano I. Gastroesophageal reflux disease: diagnosis. In: Fass R, ed. GERD/Dyspepsia: Hot Topics. Philadelphia, PA: Hanley & Belfus; 2004:41-54.
2. Wu W. Ancillary tests in the diagnosis of gastroesophageal reflux disease. Gastroenterol Clin North Am. 1990;19:671-682.
3. Dent J, Brun J, Fendrick A, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut. 1999;44:S1-S16.
4. Euler A, Byrne W. Twenty-four-hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology. 1981;80: 957-961.
5. Richter J, Castell DO. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med. 1982;97:93-103.
6. Behar J, Biancani P, Sheahan D. Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology. 1976;71:9-15.
7. Fass R, Fennerty M, Ofman J, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115:42-49.
8. Schenk B, Kuipers E, Klinkenberg-Knol E, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastro-enterol. 1997;92:1997-2000.
9. Martinez S, Malagon I, Garewal HS, et al. Non-erosive reflux disease (NERD)-acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17:537-545.
10. des Varannes SB, Mion F, Ducrotte P, et al. Simultaneous recording of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut. 2005;54:1682-1686.
11. Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroentero-logy. 2001;120:1599-1606.
12. Schindlbeck NE, Klauser AG, Voderholzer WA, et al. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med. 1995;155:1808-1812.
13. Johnsson F, Weywadt L, Solhaug J, et al. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1998;33:15-20.
14. Fass R, Ofman JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med. 1999;150:2161-2168.
15. Bate C, Riley S, Chapman R, et al. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:59-66.
16. Juul-Hansen P, Rydning A, Jacobsen C, et al. High-dose proton-pump inhibitors as a diagnostic test of gastro-esophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol. 2001;36:806-810.
17. Squillace SJ, Young MF, Sanowski RA. Abstract: single dose omeprazole as a test for noncardiac chest pain. Gastroenterology. 1993;107:A197.
18. Young MF, Sanowski RA, Talbert GA, et al. Omeprazole administration as a test for gastroesophageal reflux (abstract). Gastroenterology. 1992;102:192.
19. Pandak WM, Arezo S, Everett S, et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 2002;35:307-314.
20. Xia HH, Lai KC, Lam SK, et al. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther. 2003;17:369-377.
21. Bautista J, Fullerton H, Briseno M, et al. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain-a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 2004;19: 1123-1130.
22. Dickman R, Emmons S, Cui H, et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 2005;22: 547-555.
23. Metz D, Childs M, Ruiz C, et al. Pilot study of the oral omeprazole test of reflux laryngitis. Otolaryngol Head Neck Surg. 1997;116: 41-46.
24. Ours T, Kavuru M, Schilz R, et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999;94:3131-3138.
25. Jaspersen D, Diehl K, Geyer P, et al. Diagnostic omeprazole test in suspected reflux-associated chronic cough. Pneumologie. 1999;53: 438-441.
26. Kiljander T, Salomaa E, Heitanen E, et al. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000;16:633-638.
27. Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis. 2000;18:20-26.
28. Fass R, Ofman JJ, Sampliner RE, et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnostic gastro- oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther. 2000;14:389-396.
29. Xu G, Fang Y, Cheng N, et al. Diagnostic value of Omeprazole test in gastro-esophageal reflux disease. Chin J Dig. 2002;22:7-10.
30. Johnsson F, Hatlebakk JG, Klinterberg A-C, et al. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastro-enterol. 2003;38:354-359.
31. des Varannes SB, Sacher-Huvelin S, Vavasseur F, et al. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. World J Gastroenterol. 2006;28: 2569-2573.
32. Ho KY, Gwee KA, Khor CJ, et al. Empirical treatment for the management of patients presenting with uninvestigated reflux symptoms: a prospective study in an Asian primary care population. Aliment Pharmacol Ther. 2005;21:1313-1320.
33. Clouse R, Richter J, Heading R, et al. Functional esophageal disorders. Gut. 1999;45:II31-II36.
34. Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut. 2002;51:885-892.
35. Watson RG, Tham TC, Johnston BT, et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux-the ''sensitive esophagus''. Gut. 1997;40:587-590.
36. Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518-527.
37. Numans ME, Lau J, de Wit NJ, et al. Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics. Ned Tijdschr Geneeskd. 2004;148:1924-1928.
38. Annen MC, Weusten BLAM, Numans ME, et al. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2006;24: 1377-1384.
39. Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut. 2005;54:1067-1071.
40. Dekel R, Morse C, Fass R. The role of proton pump inhibitors in gastro-oesophageal reflux disease. Drugs. 2004;4:277-295.
41. Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32:974-979.
42. Rome III-The Functional Gastrointestinal Disorders. 3rd ed. McLean, Virginia: Degnon Associates, Inc.; 2006.
43. Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology. 1997;112: 1448-1456.
44. Chambers J, Cooke R, Anggiansah A, et al. Effect of omeprazole in patients with chest pain and normal coronary anatomy: initial experience. Int J Cardiol. 1998;65:51-55.
45. El-Serag H, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol. 2001;96:979-983.
46. Ofman JJ, Gralnek IM, Udani J, et al. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med. 1999;107:219-227.
47. Ofman JJ, Dorn G, Fennerty MB, et al. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:261-273.
48. Fass R, Malagon I, Schmulson M. Chest pain of esophageal origin. Curr Opin Gastroenterol. 2001;17:876-880.
49. Fass R. Noncardiac chest pain. In: Fass R, ed. GERD/Dyspepsia: Fast Facts. Philadelphia, PA: Hanley & Belfus; 2004:183-196.
50. Maev IV, Iurenev GL, Burkov SG, et al. Rabeprazole test and comparison of the effectiveness of course treatment with rabeprazole in patients with gastroesophageal reflux disease and non-coronary chest pain. Klin Med (Mosk). 2007;85:45-51.
51. Fass R, Pulliam G, Hayden CW. Patients with noncardiac chest pain (NCCP) receiving an empirical trial of high dose rabeprazole, demonstrate early symptom response - a double blind, placebo-controlled trial [abstract]. Gastroenterology. 2001;129:1162.
52. Fass R, Fullerton H, Hayden CW, et al. Patients with noncardiac chest pain (NCCP) receiving an empirical trial of high dose rabeprazole, demonstrate early symptom response-a double blind, placebo-controlled trial [abstract]. Gastroenterology. 2002;122: A-580-A-581, W1175.
53. Cremonini F, Wise J, Moayyedi P, et al. Meta-analysis: diagnostic and therapeutic use of proton pump inhibitors in noncardiac chest pain. Am J Gastroenterol. 2005;100:1226-1232.
54. Dekel R, Martinez-Hawthorne S, Guillen R, et al. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol. 2004;38:24-29.
55. Wang W, Huang J, Zheng G, et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? Arch Intern Med. 2005;165: 1222-1228.
56. Fass R, Fennerty MB, Johnson C, et al. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol. 1999;28:36-39.
57. McNally P, Maydonovitch C, Prosek R, et al. Evaluation of gastroesophageal reflux as a case of idiopathic hoarseness. Dig Dis Sci. 1989;34:1900-1904.
58. Kamel P, Hanson D, Kahrilas P. Omeprazole for the treatment of posterior laryngitis. Am J Med. 1994;96:321-326.
59. Field S, Sutherland L. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest. 1998;114:275-283.
60. Wo J, Grist W, Gussack G, et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol. 1997;92:2160-2165.